Interestingly, clinical data on HD revealed that the APOE ε4 allele in patient carriers delayed the age at onset of HD by a mean difference of 13.6 years, compared to ε3/ε3 patients (Panas et al., 1999). The gene discussed is APOE; the disease is Huntington disease.